447 related articles for article (PubMed ID: 21525407)
1. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
[TBL] [Abstract][Full Text] [Related]
2. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
[TBL] [Abstract][Full Text] [Related]
3. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
4. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
[TBL] [Abstract][Full Text] [Related]
5. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
[TBL] [Abstract][Full Text] [Related]
6. Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.
Liu JF; Siemian JN; Seaman R; Zhang Y; Li JX
J Neurosci; 2017 Jan; 37(4):882-892. PubMed ID: 28123023
[TBL] [Abstract][Full Text] [Related]
7. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
8. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
Xie Z; Miller GM
Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
[TBL] [Abstract][Full Text] [Related]
9. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
10. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
[TBL] [Abstract][Full Text] [Related]
11. Trace amine-associated receptor 1 modulates dopaminergic activity.
Lindemann L; Meyer CA; Jeanneau K; Bradaia A; Ozmen L; Bluethmann H; Bettler B; Wettstein JG; Borroni E; Moreau JL; Hoener MC
J Pharmacol Exp Ther; 2008 Mar; 324(3):948-56. PubMed ID: 18083911
[TBL] [Abstract][Full Text] [Related]
12. Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.
Shi X; Swanson TL; Miner NB; Eshleman AJ; Janowsky A
Mol Pharmacol; 2019 Oct; 96(4):493-504. PubMed ID: 31409621
[TBL] [Abstract][Full Text] [Related]
13. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
14. Selective TAAR1 agonists induce conditioned taste aversion.
Liu J; Wu R; Johnson B; Zhang Y; Zhu Q; Li JX
Psychopharmacology (Berl); 2022 Oct; 239(10):3345-3353. PubMed ID: 36056214
[TBL] [Abstract][Full Text] [Related]
15. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
16. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.
Siemian JN; Zhang Y; Li JX
Behav Pharmacol; 2017 Oct; 28(7):590-593. PubMed ID: 28704278
[TBL] [Abstract][Full Text] [Related]
18. TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner.
Yang SM; Ghoshal A; Hubbard JM; Gackière F; Teyssié R; Neale SA; Hopkins SC; Koblan KS; Bristow LJ; Dedic N
Neuropsychopharmacology; 2024 Jun; 49(7):1091-1103. PubMed ID: 38110609
[TBL] [Abstract][Full Text] [Related]
19. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
